CCK-8 and TUNEL assays were further performed to detect PC cell viability and apoptosis after gemcitabine treatment, which also showed GAMT could rescued the impact of RUNX2 (Fig. 8B and Supplementary Fig. 7A). This evidence concerns the gene RUNX2 and pachyonychia congenita.